Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05656248Phase 2Active Not Recruiting
Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
Myeloid Neoplasm
PrincipalinvestigatorStart date: 2023-01-17
NCT02720679Recruiting
Investigation of the Genetics of Hematologic Diseases
Blood Coagulation DisorderBone Marrow Failure SyndromesCongenital Thrombocytopenia+10 more
PrincipalinvestigatorStart date: 2016-06-17

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Raul C. Ribeiro, MD

St. Jude Children's Research Hospital

Related
2 trials

Shared therapeutic areas:

Myeloid Neoplasm

Worked with same sponsors:

Jazz PharmaceuticalsSt. Jude Children's Research Hospital
Collaborated on 1 trial
Similarity Score14%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Anemia, Sickle CellMyelodysplastic Syndromes
Similarity Score4%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesMyeloproliferative Diseases
Similarity Score4%

John F Tisdale, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Anemia, Sickle Cell

Worked with same sponsors:

St. Jude Children's Research Hospital
Similarity Score2%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score2%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score2%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score2%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score2%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score2%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05656248Phase 2PrincipalInvestigator

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Myeloid Neoplasm
Active Not Recruiting
NCT02720679PrincipalInvestigator

Investigation of the Genetics of Hematologic Diseases

Blood Coagulation DisorderBone Marrow Failure SyndromesCongenital Thrombocytopenia+10 more
Recruiting

All 2 trials loaded